lung stem cells
Cell therapyexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2016 (NCT02745184)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- lung stem cells
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02745184 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2016 | Huazhong University of Science and Technology, Regend Therapeutics |
| NCT02796781 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2016 | Huazhong University of Science and Technology, Regend Therapeutics |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Huazhong University of Science and Technology | Academic/Hospital | 2 | 2 | 1 | 2016 |
| Regend Therapeutics | For profit | 2 | 0 | 1 | 2016 |
2 organizations
Page 1 / 1